NEVVI Medicare utilization intelligence

← back

KODALI, SRINIVASM.D NPI 1295979813 Clinician

Hematology-Oncology · BEAUMONT, TX

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 27 years since medical school (class of 1999, self-reported to CMS)
Location BEAUMONT, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 71 codes billed · 98,561 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
TEXAS ONCOLOGY PA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2016-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1756 Injection, iron sucrose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J0897 Injection, denosumab, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J2469 Injection, palonosetron hcl, 25 mcg
36415 Insertion of needle into vein for collection of blood sample
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1626 Injection, granisetron hydrochloride, 100 mcg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9190 Injection, fluorouracil, 500 mg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96375 Injection of additional new drug or substance into vein
96372 Injection of drug or substance under skin or into muscle
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J9045 Injection, carboplatin, 50 mg
85055 Reticulated (young) platelet measurement
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
J3489 Injection, zoledronic acid, 1 mg
83615 Lactate dehydrogenase (enzyme) level
85018 Blood count, hemoglobin
96417 Administration of additional new drug or substance into vein, 1 hour or less
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
82784 Gammaglobulin (immune system protein) measurement
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96411 Administration of additional new drug or substance into vein using push technique
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J3490 Unclassified drugs
83735 Magnesium level
J7030 Infusion, normal saline solution , 1000 cc
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96523 Irrigation of implanted venous access drug delivery device
83521 Measurement of immunoglobulin light chains
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96361 Infusion into a vein for hydration, each additional hour
82270 Stool analysis for blood to screen for colon tumors
84550 Uric acid level, blood
71260 Ct scan of chest with contrast
85045 Red blood count, automated test
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96360 Infusion into a vein for hydration, 31-60 minutes
74177 Ct scan of abdomen and pelvis with contrast
99195 Drawing of blood for a medical problem
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
38222 Biopsy and aspiration of bone marrow sample for diagnosis
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99236 Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
71250 Ct scan of chest without contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.